A North Wales MS has called for joint action to resolve what he described as long-running parking problems at Wrexham Maelor ...

Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint in delaying time to ...

Tolebrutinib received provisional approval in the United Arab Emirates in July 2025 for non-relapsing secondary progressive ...

Mendoza has used the spotlight of being a Heisman frontrunner to highlight his mother’s fight — he calls her his “light and inspiration” — and the positivity and optimism she brings to his life.

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of the disease didn’t hit its main goal.

Two medical professionals who live near Bondi Beach, where gunmen attacked a Hanukkah festival on Sunday, described a ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated ...

NIMS nursing officers protest for long-pending demands, briefly locked inside hospital premises during a rally in Hyderabad.

Last month, a frantic call came into the National Fire Agency’s 119 Safety Reporting Center. A family member reported that Ms. A, a woman in her 70s living in northern Seoul, was vomiting blood.

The number of critical patients having to travel interstate to receive CAR T-cell therapy will be reduced from mid-next year, with SA to launch a service at the Royal Adelaide Hospital.

A research breakthrough in Western Australia has helped explain the mystery of historically low survival rates among ...